Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05919069
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-11
First Post:
2023-06-16
Brief Title:
A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK Safety and Tolerability of AZD2693
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-16
First Submit QC Date:
June 16 2023
Study First Post Date:
2023-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-30
Last Update Post Date:
2024-06-11
Last Update Post Date Type:
ACTUAL